✦ LIBER ✦

Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia

✍ Scribed by Barosi, G. ;Liberato, L. N. ;Costa, A. ;Ascari, E.

Publisher: Springer-Verlag
Year: 1989
Weight: 393 KB
Volume: 58
Category: Article
ISSN: 1432-0584
DOI: 10.1007/bf00320164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dysregulation and overexpression of HMGA

Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia

✍ Joris Andrieux; Jean-Loup Demory; Brigitte Dupriez; Sabine Quief; Isabelle Plant 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Among cytogenetic studies of patients affected with myelofibrosis with myeloid metaplasia (MMM), a rare chronic myeloproliferative disorder, we found several reports of structural abnormalities of the long arm of chromosome 12. Two MMM patients had a balanced translocation involving 12q: t(4;12)(q32

Prognostic relevance of cytogenetics det

Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia

✍ Kathrin Strasser-Weippl; Michael Steurer; Mathias Kees; Florian Augustin; Alexan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Decreased JAK2 V617F allele burden level

Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation

✍ Yi-Ying Wu; Hsiu-Man Hung; Tien-Sheng Chen; Tsu-Yi Chao; Ching-Liang Ho 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 243 KB

A Pleural Effusion Caused by Fibrous Hem

A Pleural Effusion Caused by Fibrous Hematopoietic Tumor Successfully Treated With Prednisolone in a Patient With Agnogenic Myeloid Metaplasia With Myelofibrosis

✍ Yasuo Hirayama; Ryuzo Koyama; Tadanori Nagai; Takuya Matsunaga; Katsuhisa Kogawa 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 656 KB

Treatment with natural human interferon

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2 b

✍ Freund, M. ;Wussow, P. ;Kn�ver-Hopf, J. ;Mohr, H. ;Pohl, U. ;Exeriede, G. ;Link, 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 437 KB

Leukemogenic risk of hydroxyurea therapy

Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

✍ Nand, Sucha; Stock, Wendy; Godwin, John; Fisher, Susan Gross 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

In polycythemia Vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%. This risk has been estimated to be 1-5.9% with hydroxyurea (HU) therapy. When compared with historical controls, the risk with use of HU does not a